Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Genie29jon Sep 26, 2023 8:02pm
143 Views
Post# 35655920

RE:RE:RE:RE:RE:RE:Head fake, or the real deal?

RE:RE:RE:RE:RE:RE:Head fake, or the real deal?

Yes, case in point the title of this subject line. “Head fake or the real deal"

injiboy - I was thinking the same, but I think toni is correct... if Replicel wins, but there's no deal / partnership... it will take years and a $hit ton of more investments. Plus, if Replicel wins and there's no deal, could this be a result of less than satisfactory results. 


and then there's the device... we've been hearing the same narrative for the past 5-10 years. 

in the end, it's about "show me the money" - at least for me anyway. I'd rather buy at $1 knowing positive news is finally baked in and there's a clear path vs. buying at these awful prices and losing even more / everything is simply not appealing

The company is broke - money is going out and nothing is coming in. IMO if there's no Shiseido partnership by the end of all this, either kiss your "investment" good-bye or pray Andrew and Jamie keep funding the program. 

 
<< Previous
Bullboard Posts
Next >>